Skip to content Skip to menu

Pharma companies set high ethical standard

Friday, 25 July 2008

Media Release

Medicines Australia today published its Code of Conduct Annual Report, which documents all determinations made by the independent Code of Conduct Committee during 2007-08.

The report includes the outcomes of the 52 complaints arising from the 14,633 educational events that made up the first educational events report, published in March 2008.

Of those 52 complaints, the Code of Conduct Committee found only 21 to be in breach of the Code of Conduct – a compliance rate of 99.8 per cent.

In addition to the complaints arising from the educational events report, the Annual Report lists 24 finalised complaints that were referred through other channels. In 2006/07 a total of 38 complaints were finalised.

Medicines Australia chief executive Ian Chalmers said the Code of Conduct Annual Report showed that overwhelmingly, member companies are committed to a very high ethical standard of corporate behaviour.

“More than 99.8 per cent of events included in the March 2008 educational event reports complied with the Code of Conduct,” Mr Chalmers said.

“This shows how seriously member companies take their responsibility to engage healthcare professionals in an ethical manner.

“Medicines Australia is disappointed by any breach of the Code of Conduct. We are aiming for 100 per cent compliance with the Code. Breaches can’t be tolerated and won’t be tolerated.”

The vast majority of breaches identified in the Annual Report were either referred by the independent educational event auditor, or were complaints brought by Medicines Australia member companies.

“This shows that we have in place a very rigorous and effective system of selfregulation. It’s independent, it’s transparent and it works,” Mr Chalmers said.

The Code of Conduct sets a high ethical standard for marketing and promotion of prescription pharmaceuticals.

The Annual Report is available from here

–ENDS–

Contact Person:

Jamie Nicholson
Media Communications Manager
Phone: 0419 220 293
Email:
Jamie.Nicholson@medicinesaustralia.com.au

Information

As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at medicinesaustralia.com.au/covid-19/

Top